Compounds > n-(n-(3-carboxyoxirane-2-carbonyl)leucyl)isoamylamine
Page last updated: 2024-09-03

n-(n-(3-carboxyoxirane-2-carbonyl)leucyl)isoamylamine and rupintrivir

n-(n-(3-carboxyoxirane-2-carbonyl)leucyl)isoamylamine has been researched along with rupintrivir in 1 studies

Compound Research Comparison

Studies
(n-(n-(3-carboxyoxirane-2-carbonyl)leucyl)isoamylamine)		Trials
(n-(n-(3-carboxyoxirane-2-carbonyl)leucyl)isoamylamine)		Recent Studies (post-2010)
(n-(n-(3-carboxyoxirane-2-carbonyl)leucyl)isoamylamine)		Studies
(rupintrivir)		Trials
(rupintrivir)		Recent Studies (post-2010) (rupintrivir)
7911669242

Protein Interaction Comparison

ProteinTaxonomyn-(n-(3-carboxyoxirane-2-carbonyl)leucyl)isoamylamine (IC50)rupintrivir (IC50)
Genome polyprotein Human rhinovirus sp.0.023

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Moreira, R; Santos, MM1

Reviews

1 review(s) available for n-(n-(3-carboxyoxirane-2-carbonyl)leucyl)isoamylamine and rupintrivir

ArticleYear
Michael acceptors as cysteine protease inhibitors.
    Mini reviews in medicinal chemistry, 2007, Volume: 7, Issue:10

    Topics: Animals; Cysteine Proteinase Inhibitors; Drug Design; Humans; Isoxazoles; Leucine; Molecular Structure; Oxazoles; Peptides; Phenylalanine; Pyrrolidines; Pyrrolidinones; Structure-Activity Relationship; Sulfones; Valine

2007